The Division of Pediatric Endocrinology & Diabetes

The work of this division successfully combines the worlds of investigation, innovation, and clinical care to improve the diagnosis and treatment of endocrine disorders.

Patient Care

The Division of Pediatric Endocrinology and Diabetes at Stanford has a long tradition of providing quality clinical care of children and adolescents across the board range of pediatric endocrinology disorders.

Patients, contact the endocrinology & diabetes clinic.

More about patient care 

Research

The Division of Pediatric Endocrinology and Diabetes at Stanford is actively involved in basic, translational, and clinical research.

 

Education

The Division's Fellowship Program ensures future generations of physicians can achieve an in-depth understanding of patient care surrounding a wide range of pediatric endocrinology disorders.

Announcements

David Scheinker, PhD joins the Division of Pediatric Endocrinology and Diabetes

Concurrently with his appointment to Pediatric Endocrinology, David Scheinker is an Adjunct Professor in the Department of Management Science and Engineering and The Director of Systems Design and Collaborative Research at the Stanford Lucile Packard Children's Hospital. His appointments in the School of Medicine, School of Engineering, and the Children's Hospital are designed to facilitate collaboration between the three institutions. To foster such collaboration he founded and directs SURF Stanford Medicine, a group that brings together students and faculty from the Schools of Medicine and Engineering with nurses and administrators from the Children's Hospital to improve the quality and reduce the cost of care using operations research methodology. SURF is currently working with other faculty in  Pediatric Endocrinology to develop tools to detect and predict deteriorating glucose control and develop personalized care responses for Type 1 Diabetes using continuous glucose monitor data. David also serves on the faculty of Stanford's Clinical Excellence Research Center where he works on transforming SURF's hospital projects into broader interventions that have the potential to reduce the nationwide cost of high quality care.

David received a BA and an MA in Mathematics from The University of Pennsylvania in 2005 and a PhD in Theoretical Math from the University of California San Diego under Jim Agler in 2011. Before coming to Stanford, David was a Joint Research Fellow at The MIT Sloan School of Management and Massachusetts General Hospital. His current areas of research include  the applications of operations research in healthcare, mathematical control theory, and functional analysis. David has spent time teaching theoretical math to gifted 11 and 12 year old students for the Johns Hopkins Center for Talented Youth. He is writing a popular math book titled Infinity in Wonderland with the intent to bring the material of these courses to a wider audience.

Is the Surgical World Ready for Adolescent Gender Surgery? | Tandy Aye, MD | TEDXUniversityofNevada

TEDx link: https://youtu.be/L240CPOJ6FM

Dr Appel now has a ‘courtesy appointment’ in the division

The Appel lab develops new technologies to enable next-generation biopharmaceutical formulations. Dr Appel has a strong interest in engineering new insulin formulations that can address long-standing challenges with current formulations to enhance the management of diabetes. Dr Appel’s research is funded by an R01 from the NIDDK, a Junior Faculty Development Award from the American Diabetes Association, and a Stanford Diabetes Research Center Pilot & Feasibility award funded by the Maternal Child Health Research Institute. Dr Appel’s research on insulin formulations complements the clinical research in the division on diabetes technology including work on the artificial pancreas. Dr Appel serves as a basic science advisor for fellows and faculty in the area of insulin formulations and an educational resource for trainees and faculty for the science of insulin and other hormonal therapies that are essential to clinical practice in pediatric endocrinology. More information can be found at www.supramolecularbiomaterials.com.

 

 

ISPAD Innovation

Congratulations to Dr. Bruce Buckingham who has been awarded the 2018 JDRF David Rumbough Award and the ISPAD Prize for Innovation in Pediatric Diabetes Care.

See this link for description of the Prize: https://www.ispad.org/page/ISPADPrizes   

See this link for description of Bruce’s work: https://www.ispad.org/page/Innovation2018

Employee of the Month!

Congratulations to Ofelia Colin, Administrative Associate in Pediatric Endocrinology, for being awarded the Employee of the Month. Ofelia has worked in the Department for 15 years! 

PES Award 

Congratulations to Ananta Addala, DO, MPH, Fellow in Pediatric Endocrinology, for being awarded as one of the winners of the current cycle of Rising Star Awards. The purpose of this small grant award is to support and encourage research efforts to fellows. The PES will fund a maximum of 5 grants every 6 months. 

New Arrivals

Our newest fellows, Walter Zegarra and Holly Cooper, bonded during the department orientation July 6. They joined 46 pediatrics fellows across the department in team building activities like rock climbing and rope swings at the Arillaga Outdoor Education Recreation Center (AOERC) on campus. Welcome, Holly and Walter!


Maahs Presents on Novel Glucose Monitoring at ChildX and How the Stanford Diabetes Technology Team is Leading the Way Forward in Research

David Maahs, MD, PhD, Association Director of the Stanford Diabetes Research Center; Division Chief and Professor of Pediatrics (Endocrinology), spoke at ChildX conference at Stanford on April 13, 2018 on Next Generation Management of Chronic Illnesses: Technology for Real-Time Monitoring. Dr. Maahs addressed how novel approaches to monitoring and reporting blood glucose level are changing the way that care is delivered to children with diabetes.   

Watch the video or see the conference program here.


Feature: Stanford Diabetes Research Center  

Learn more about the Diabetes Research Center and its work! David Maahs, MD, PhD, Association Director of the Stanford Diabetes Research Center; Division Chief and Professor of Pediatrics (Endocrinology), is featured in a Stanford Diabetes Clinic video.

Watch the video here. Dr. Maahs' research focuses on improving care and preventing complications in people with type 1 diabetes (T1D).  

Visit Dr. Maahs' profiles at the NIH consortium of Diabetes Research Centers and Stanford School of Medicine.

Division Activities

It's a Match! - Holly Cooper & Walter Zegarra to Join Fellowship Program

We are thrilled to announce that on December 13, our fellowship training program matched two out of two positions. We look forward to welcoming Holly Cooper, MD from UCLA and Walter Zegarra, MD from University of Miami to our team beginning July 7th, 2018.


Division Founder's Legacy Honored

50 Years Ago in The Journal of Pediatrics is a brief reflection on the prolific and ground-breaking work of Raymond Hintz, MD, founder of the Division of Pediatric Endocrinology at Stanford School of Medicine and author of over 350 publications.

Maria Chang, MD (fellow), Darrell Wilson, MD (faculty), and David Maahs, MD, PhD (chief) recall Hintz' first publication, Familial Holoprosencephaly with Endocrine Dysgenesis (1968), in a December 26, 2017 Journal of Pediatrics column. Read more about Hintz at Stanford Medicine Scope.


Notices

We're Open! - New Packard Children's Hospital

Lucile Packard Children’s Hospital Stanford has created one of America’s most technologically advanced, family-friendly and environmentally sustainable hospitals for babies, children and pregnant women. The new hospital, opened its doors to patients on December 9, 2017 adding 521,000 square feet of building space and 149 patient beds to its facility.

The patient rooms are now private and feature a bathroom with shower, fold-out bed and privacy curtains so families have the option to stay in-room with their child. Computer workspace, child broadcast center, playground, kitchen and laundry help support families during their stay.

Animas shutting down US operations for insulin pumps

On October 5, 2017, Johnson and Johnson and Animas pump company have confirmed they will shut down U.S. operations, and exit the insulin pump market. They have selected Medtronic as their partner-of-choice, and are offering their patients to switch to Medtronic insulin pumps. Current Animas users can continue using their current pump, and will be able to get their Animas pump supplies (reservoirs and infusion sets) from the vendor. 

New FIASP insulin approved for adults

On September 29, 2017, the FDA approved the new Novo Nordisk FIASP insulin for adults. This is a faster acting meal time insulin, that can be used instead of Humalog or Novolog. Check with your insurance company to determine whether or not this is a product on your formulary.

Freestyle Libre Flash CGM approved for adults

On September 27, 2017, the FDA approved the Freesyle Libre Flash Continuous Glucose Monitor (CGM) system in adults 18 years old and up. The sensor is factory calibrated, meaning it does not require any fingerstick calibrations. The sensor can be worn for up to 10 days, after a 12 hour warm up phase.

Transgender: Caring for kids making the transition

“As a child, Noah Wilson thought gender meant boy or girl, the end. But when they were both 14, Noah’s best friend, Rory, came out as nonbinary, a person who feels neither squarely male nor female.”

Hybrid closed-loop insulin delivery systems for Type 1 diabetes come of age

“The closed-loop system has completely changed our lives,” Sara said. “It took me a month to trust it, but now I can go to bed at 11 p.m. and wake up at 6:30 a.m. almost every night.”

This multidisciplinary clinic provides medical services for gender nonconforming youths and their families in one central location. The expert members of the Gender Clinic team consists of providers from pediatric endocrinology, adolescent medicine, pediatric urology and social services, supporting each child’s or adolescent’s gender identity. All our providers are members of the World Professional Association for Transgender Health (WPATH).

At Stanford Children’s Health, we bring experts in endocrinologyorthopedics, adolescent medicinegenetics and nephrology together to provide the best possible treatments for primary and secondary osteoporosis.

The pediatric endocrine bone health team at Stanford Children’s Health is nationally ranked in Diabetes & Endocrinology by U.S. News & World Report and treats children with endocrine disorders at our Welch Road clinic.

The mission of the Stanford Diabetes Research Center is to support basic and clinical research to discover, apply and translate science about diabetes and it complications, to improve health and wellness.

 Join our mailing list

Subscribe to the pediatric endocrinology mailing list and receive emails regarding diabetes and the pediatric diabetes program here at Stanford.